BPG is committed to discovery and dissemination of knowledge
Systematic Reviews
Copyright ©The Author(s) 2025.
World J Cardiol. Sep 26, 2025; 17(9): 110061
Published online Sep 26, 2025. doi: 10.4330/wjc.v17.i9.110061
Table 1 Characteristics of the selected studies
Ref.
Study design
Population characteristics
Sample size
Intervention (CCTA)
Comparator (stress testing)
Outcomes measured
Key findings
Follow-up duration
Singh et al[11]Post hoc of RCTAdults aged 18-75 with suspected stable angina; Scotland clinics3283CCTA as add-on to standard careExercise ECGCHD death, nonfatal MI, diagnostic accuracyCCTA more predictive of CHD death/MI (HR 10.63); ECG: 39% sensitivity, 91% specificity5 years
Stillman et al[12]Multicenter RCTStable angina, intermediate risk; 44 sites1050CCTA to guide therapy/revascularizationSPECT MPIMACE (MI, cardiac death), revascularizationSimilar outcomes (HR 1.03); CCTA better predicted MACE; fewer events in CCTA-negative patientsMean 16.2 months
Lubbers et al[13]Multicenter RCTStable angina; Dutch outpatient clinics350Tiered: CAC → CCTAFunctional (ECG, MPI, echo)Event-free survival, symptoms, downstream testing, costHigher survival (96.7% vs 89.8%, P = 0.011); less downstream testing; lower cost1.2 years
Lubbers et al[14]Multicenter RCTStable angina; mean pretest CAD probability 54%268Tiered: CAC → CCTA → CT perfusion (if needed)Functional (mostly exercise ECG)Angiograms w/ and w/o revascularization, further testing, efficiencyFewer unnecessary angiograms (1.5% vs 7.2%, P = 0.035); more revascularizations (88% vs 50%, P = 0.017)6 months
Linde et al[15]RCTAcute chest pain with normal ECG/troponin600CCTA-guided; functional added if neededStandard: Bicycle ECG or MPIComposite: Death, MI, UAP, revascularization, readmissionFollow-up
Table 2 Comparative outcomes between coronary computed tomography angiography and stress testing
Ref.
Sample Size
CCTA modality
Stress test comparator
Primary outcome(s)
Hazard ratio/statistics
Follow-up duration
Key findings
Singh et al[11]3283CCTA as add-on to standard careExercise ECGCHD death or nonfatal MI; diagnostic accuracyHR for CHD death/MI: 10.63; ECG Sensitivity: 39%, Specificity: 91%5 yearsCCTA strongly predicted CHD events; superior diagnostic accuracy over ECG
Stillman et al[12]1050 (CCTA: 518; SPECT: 532)CCTA to guide therapy and revascularizationSPECT MPIMACE (MI or cardiac death); revascularizationHR 1.03 (NS); Event rate: 1.2% (CCTA-negative) vs 3.2% (SPECT-negative)Mean 16.2 monthsCCTA better identified patients at low risk and those needing revascularization
Lubbers et al[13]350Tiered approach: CAC → CCTAECG, MPI, or EchoEvent-free survival; anginal symptoms; costEvent-free survival: 96.7% (CCTA) vs 89.8% (Functional), P = 0.0111.2 yearsHigher event-free survival and cost-effectiveness in the CCTA group
Lubbers et al[14]268 (CT: 130; Functional: 138)CAC → CCTA → CT perfusion (if needed)Mostly Exercise ECGAngiograms (with/without revascularization); further testingUnnecessary angiograms: 1.5% vs 7.2%, P = 0.035; Revascularization: 88% vs 50%, P = 0.0176 monthsCCTA reduced unnecessary procedures; improved selection for revascularization
Linde et al[15]600 (CCTA: 299; Control: 301)CCTA-guided strategyBicycle ECG or MPIComposite: MI, cardiac death, UAP, revascularization, readmissionComposite events: 11% (CCTA) vs 16% (Control), HR 0.62, P = 0.04; MACE HR: 0.36Median 18.7 monthsControl
Table 3 Risk of bias assessment of included studies
Ref.
Randomization process
Deviations from intended interventions
Missing outcome data
Measurement of outcome
Selection of the reported result
Overall risk of bias
Singh et al[11]LowLowLowLowLowLow
Stillman et al[12]LowLowLowLowSome concerns (limited outcome events may impact reporting)Some concerns
Lubbers et al[13]LowLowLowLowLowLow
Lubbers et al[14]LowLowLowLowLowLow
Linde et al[15]LowLowLowLowLowLow